These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
241 related items for PubMed ID: 11893219
21. Naftifine. A review of its antimicrobial activity and therapeutic use in superficial dermatomycoses. Monk JP, Brogden RN. Drugs; 1991 Oct; 42(4):659-72. PubMed ID: 1723367 [Abstract] [Full Text] [Related]
22. Luliconazole for the treatment of fungal infections: an evidence-based review. Khanna D, Bharti S. Core Evid; 2014 Oct; 9():113-24. PubMed ID: 25285056 [Abstract] [Full Text] [Related]
23. KP-103, a novel triazole derivative, is effective in preventing relapse and successfully treating experimental interdigital tinea pedis and tinea corporis in guinea pigs. Tatsum Y, Yokoo M, Arika T, Yamaguchi H. Microbiol Immunol; 2002 Oct; 46(7):425-32. PubMed ID: 12222928 [Abstract] [Full Text] [Related]
28. Terbinafine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial mycoses. Balfour JA, Faulds D. Drugs; 1992 Feb; 43(2):259-84. PubMed ID: 1372222 [Abstract] [Full Text] [Related]
29. New Antifungal Agents and New Formulations Against Dermatophytes. Gupta AK, Foley KA, Versteeg SG. Mycopathologia; 2017 Feb; 182(1-2):127-141. PubMed ID: 27502503 [Abstract] [Full Text] [Related]
30. Antimycotic efficacy of bifonazole in vitro and in vivo. Plempel M, Regel E, Büchel KH. Arzneimittelforschung; 1983 Feb; 33(4):517-24. PubMed ID: 6683530 [Abstract] [Full Text] [Related]
31. Effects of butenafine hydrochloride, a new benzylamine derivative, on experimental dermatophytosis in guinea pigs. Arika T, Yokoo M, Hase T, Maeda T, Amemiya K, Yamaguchi H. Antimicrob Agents Chemother; 1990 Nov; 34(11):2250-3. PubMed ID: 2073116 [Abstract] [Full Text] [Related]
32. Antifungal activity of the new agent latoconazole in two tinea models. Ohmi T, Konaka S, Uchida M, Yamaguchi H. Arzneimittelforschung; 1991 Aug; 41(8):847-51. PubMed ID: 1781809 [Abstract] [Full Text] [Related]
34. In vitro activity of novel imidazole antifungal agent NND-502 against Malassezia species. Uchida K, Nishiyama Y, Tanaka T, Yamaguchi H. Int J Antimicrob Agents; 2003 Mar; 21(3):234-8. PubMed ID: 12636984 [Abstract] [Full Text] [Related]
35. In vitro and in vivo studies with flutrimazole, a new imidazole derivative with antifungal activity. García Rafanell J, Dronda MA, Merlos M, Forn J, Torres JM, Zapatero MI, Basi N. Arzneimittelforschung; 1992 Jun; 42(6):836-40. PubMed ID: 1418042 [Abstract] [Full Text] [Related]
37. Experimental and clinical investigation on oxiconazole. Wu SX, Shen YN, Yan N, Guo NR, Liu LL, Yang JQ. Chin Med J (Engl); 1989 Aug; 102(8):644-6. PubMed ID: 2517622 [Abstract] [Full Text] [Related]
39. Optimal management of fungal infections of the skin, hair, and nails. Gupta AK, Cooper EA, Ryder JE, Nicol KA, Chow M, Chaudhry MM. Am J Clin Dermatol; 2004 Aug; 5(4):225-37. PubMed ID: 15301570 [Abstract] [Full Text] [Related]